MedTrace Logo

TRI-V Heart Failure (HF) Implanted Cardioverter Defibrillator (ICD) Study

NCT00746135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2019-02-04

No results posted yet for this study

Summary

It's the aim of this study to investigate the impact of Right Ventricular (RV) lead position (RV-apex, His bundle area, RV-apex+His bundle area) in combination with individually optimized Left Ventricular (LV) lead placement and CRT timing on the outcome of cardiac resynchronization therapy (CRT).

Conditions

Interventions

DEVICE

Device Implantation

RV apical pacing lead, RV pacing lead at HIS bundle position, LV pacing lead implantation

Sponsors & Collaborators

  • Abbott Medical Devices

    lead INDUSTRY

Principal Investigators

  • Wolfgang Kranig, MD · Departement of Cardiology - Electrophysiology- Heart Centre Osnabrück - Bad Rothenfelde

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2010-10-31
Completion
2012-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00746135 on ClinicalTrials.gov